Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib-IIa Study of Anfibatide in NSTEMI Patients
CTR20150092Phase 2Completed
- Sponsor
- Hefei Zhaofeng Keda Pharmaceutical
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anfibatide in Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Hefei Zhaofeng Keda Pharmaceutical. Started Mar 2015; status: completed.
02
Drugs
anfibatide
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on CTR20150092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150092.